YHC3/YJL059W Literature Guide Help

Other names published for YHC3: BTN1, YJL059W

YHC3 - Primary Literature (24)

ReferenceOther Genes Addressed
Arlt H, et al.  (2011) An overexpression screen in Saccharomyces cerevisiae identifies novel genes that affect endocytic protein trafficking. Traffic 12(11):1592-603
Kama R, et al.  (2011) The yeast Batten disease orthologue Btn1 controls endosome-Golgi retrograde transport via SNARE assembly. J Cell Biol 195(2):203-15
Wolfe DM, et al.  (2011) pH-dependent localization of Btn1p in the yeast model for Batten disease. Dis Model Mech 4(1):120-125
Lopez-Garcia B, et al.  (2010) A genomic approach highlights common and diverse effects and determinants of susceptibility on the yeast Saccharomyces cerevisiae exposed to distinct antimicrobial peptides. BMC Microbiol 10():289
Vitiello SP, et al.  (2010) Interaction between Sdo1p and Btn1p in the Saccharomyces cerevisiae model for Batten disease. Hum Mol Genet 19(5):931-42
Osorio NS, et al.  (2007) Nitric oxide signaling is disrupted in the yeast model for Batten disease. Mol Biol Cell 18(7):2755-67
Vitiello SP, et al.  (2007) Absence of Btn1p in the yeast model for juvenile Batten disease may cause arginine to become toxic to yeast cells. Hum Mol Genet 16(9):1007-16
Padilla-Lopez S and Pearce DA  (2006) Saccharomyces cerevisiae lacking Btn1p modulate vacuolar ATPase activity to regulate pH imbalance in the vacuole. J Biol Chem 281(15):10273-80
Kim Y, et al.  (2005) Interaction among Btn1p, Btn2p, and Ist2p reveals potential interplay among the vacuole, amino acid levels, and ion homeostasis in the yeast Saccharomyces cerevisiae. Eukaryot Cell 4(2):281-8
Ramirez-Montealegre D and Pearce DA  (2005) Defective lysosomal arginine transport in juvenile Batten disease. Hum Mol Genet 14(23):3759-73
Chattopadhyay S, et al.  (2003) The yeast model for Batten disease: a role for Btn2p in the trafficking of the Golgi-associated vesicular targeting protein, Yif1p. Biochem Biophys Res Commun 302(3):534-8
Kim Y, et al.  (2003) A role in vacuolar arginine transport for yeast Btn1p and for human CLN3, the protein defective in Batten disease. Proc Natl Acad Sci U S A 100(26):15458-62
Chattopadhyay S and Pearce DA  (2002) Interaction with Btn2p is required for localization of Rsglp: Btn2p-mediated changes in arginine uptake in Saccharomyces cerevisiae. Eukaryot Cell 1(4):606-12
Teixeira MT, et al.  (2002) Genome-wide nuclear morphology screen identifies novel genes involved in nuclear architecture and gene-silencing in Saccharomyces cerevisiae. J Mol Biol 321(4):551-61
Chattopadhyay S, et al.  (2000) The yeast model for batten disease: mutations in BTN1, BTN2, and HSP30 alter pH homeostasis. J Bacteriol 182(22):6418-23
Haskell RE, et al.  (2000) Batten disease: evaluation of CLN3 mutations on protein localization and function. Hum Mol Genet 9(5):735-44
Pearce DA, et al.  (1999) Action of BTN1, the yeast orthologue of the gene mutated in Batten disease. Nat Genet 22(1):55-8
Pearce DA, et al.  (1999) Phenotypic reversal of the btn1 defects in yeast by chloroquine: a yeast model for Batten disease. Proc Natl Acad Sci U S A 96(20):11341-5
Pearce DA, et al.  (1999) Studies of pH regulation by Btn1p, the yeast homolog of human Cln3p. Mol Genet Metab 66(4):320-3
Croopnick JB, et al.  (1998) The subcellular location of the yeast Saccharomyces cerevisiae homologue of the protein defective in the juvenile form of Batten disease. Biochem Biophys Res Commun 250(2):335-41
Pearce DA and Sherman F  (1998) A yeast model for the study of Batten disease. Proc Natl Acad Sci U S A 95(12):6915-8
Mitchison HM, et al.  (1997) Structure of the CLN3 gene and predicted structure, location and function of CLN3 protein. Neuropediatrics 28(1):12-4
Pearce DA and Sherman F  (1997) BTN1, a yeast gene corresponding to the human gene responsible for Batten's disease, is not essential for viability, mitochondrial function, or degradation of mitochondrial ATP synthase. Yeast 13(8):691-7
Taschner PE, et al.  (1997) Cross-species homology of the CLN3 gene. Neuropediatrics 28(1):18-20